122 related articles for article (PubMed ID: 10697747)
1. Anionic mucoadhesive polymers as auxiliary agents for the peroral administration of (poly)peptide drugs: influence of the gastric juice.
Bernkop-Schnürch A; Gilge B
Drug Dev Ind Pharm; 2000 Feb; 26(2):107-13. PubMed ID: 10697747
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, development and in vitro evaluation of drug delivery systems with protective effect against degradation by pepsin.
Bernkop-Schnürch A; Kirchmayer R; Kratzel M
J Drug Target; 1999; 7(1):55-63. PubMed ID: 10614815
[TBL] [Abstract][Full Text] [Related]
3. Auxiliary agents for the peroral administration of peptide and protein drugs: synthesis and evaluation of novel pepstatin analogues.
Kratzel M; Hiessböck R; Bernkop-Schnürch A
J Med Chem; 1998 Jun; 41(13):2339-44. PubMed ID: 9632367
[TBL] [Abstract][Full Text] [Related]
4. Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo.
Luessen HL; de Leeuw BJ; Langemeÿer MW; de Boer AB; Verhoef JC; Junginger HE
Pharm Res; 1996 Nov; 13(11):1668-72. PubMed ID: 8956332
[TBL] [Abstract][Full Text] [Related]
5. Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin.
Luessen HL; Verhoef JC; Borchard G; Lehr CM; de Boer AG; Junginger HE
Pharm Res; 1995 Sep; 12(9):1293-8. PubMed ID: 8570524
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional matrices for oral peptide delivery.
Bernkop-Schnürch A; Walker G
Crit Rev Ther Drug Carrier Syst; 2001; 18(5):459-501. PubMed ID: 11763498
[TBL] [Abstract][Full Text] [Related]
7. Thiomers: potential excipients for non-invasive peptide delivery systems.
Bernkop-Schnürch A; Krauland AH; Leitner VM; Palmberger T
Eur J Pharm Biopharm; 2004 Sep; 58(2):253-63. PubMed ID: 15296953
[TBL] [Abstract][Full Text] [Related]
8. New mucoadhesive polymeric film for ophthalmic administration of acetazolamide.
Tártara LI; Palma SD; Allemandi D; Ahumada MI; Llabot JM
Recent Pat Drug Deliv Formul; 2014; 8(3):224-32. PubMed ID: 25198555
[TBL] [Abstract][Full Text] [Related]
9. [Mucoadhesive tablets for oral administration of ciclopiroxolamine].
Kuna M; Rabisková M
Ceska Slov Farm; 2007 Oct; 56(5):243-8. PubMed ID: 18064806
[TBL] [Abstract][Full Text] [Related]
10. Chitosan and its derivatives: potential excipients for peroral peptide delivery systems.
Bernkop-Schnürch A
Int J Pharm; 2000 Jan; 194(1):1-13. PubMed ID: 10601680
[TBL] [Abstract][Full Text] [Related]
11. Insights into the mechanisms of chitosan-anionic polymers-based matrix tablets for extended drug release.
Li L; Wang L; Li J; Jiang S; Wang Y; Zhang X; Ding J; Yu T; Mao S
Int J Pharm; 2014 Dec; 476(1-2):253-65. PubMed ID: 25290814
[TBL] [Abstract][Full Text] [Related]
12. Gastro-resistant characteristics of GRAS-grade enteric coatings for pharmaceutical and nutraceutical products.
Czarnocka JK; Alhnan MA
Int J Pharm; 2015; 486(1-2):167-74. PubMed ID: 25796126
[TBL] [Abstract][Full Text] [Related]
13. [Absorption of calcitonin in oral and pulmonary administration with polymer-coated liposomes].
Takeuchi H; Sugihara H
Yakugaku Zasshi; 2010 Sep; 130(9):1135-42. PubMed ID: 20823671
[TBL] [Abstract][Full Text] [Related]
14. Design and in vivo evaluation of an oral delivery system for insulin.
Marschütz MK; Caliceti P; Bernkop-Schnürch A
Pharm Res; 2000 Dec; 17(12):1468-74. PubMed ID: 11303955
[TBL] [Abstract][Full Text] [Related]
15. Modulation of stability and mucoadhesive properties of chitosan microspheres for therapeutic gastric application.
Fernandes M; Gonçalves IC; Nardecchia S; Amaral IF; Barbosa MA; Martins MC
Int J Pharm; 2013 Sep; 454(1):116-24. PubMed ID: 23850814
[TBL] [Abstract][Full Text] [Related]
16. The relationship between the content of aggressive and protective components in gastric juice and endoscopic findings after naproxen sodium and acetaminophen administration.
Marcinkiewicz M; Peura DA; Sarosiek J
Am J Gastroenterol; 1996 Feb; 91(2):360-5. PubMed ID: 8607507
[TBL] [Abstract][Full Text] [Related]
17. Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract.
Lehr CM
Crit Rev Ther Drug Carrier Syst; 1994; 11(2-3):119-60. PubMed ID: 7600586
[TBL] [Abstract][Full Text] [Related]
18. Leakage of enteric (Eudragit L)-coated dosage forms in simulated gastric juice in the presence of poly(ethylene glycol).
Breitkreutz J
J Control Release; 2000 Jun; 67(1):79-88. PubMed ID: 10773331
[TBL] [Abstract][Full Text] [Related]
19. DEVELOPMENT OF COMPRESSED COATED POLYPILL WITH MUCOADHESIVE CORE COMPRISING OF ATORVASTATIN/CLOPIDOGREL/ASPIRIN USING COMPRESSION COATING TECHNIQUE.
Shahid N; Adnan S; Farooq M; Ali S; Shabbir M; Masood Z; Waqar K; Saleem H; Gill SA; Ali T
Acta Pol Pharm; 2017 Mar; 74(2):477-487. PubMed ID: 29624252
[TBL] [Abstract][Full Text] [Related]
20. Rheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of poloxamer 407 and carbopol 974P designed as platforms for implantable drug delivery systems for use in the oral cavity.
Jones DS; Bruschi ML; de Freitas O; Gremião MP; Lara EH; Andrews GP
Int J Pharm; 2009 May; 372(1-2):49-58. PubMed ID: 19429268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
